Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
98,685,316
-
Total 13F shares
-
136,443,326
-
Share change
-
+566,417
-
Total reported value
-
$852,764,205
-
Put/Call ratio
-
75%
-
Price per share
-
$6.25
-
Number of holders
-
151
-
Value change
-
+$5,539,636
-
Number of buys
-
66
-
Number of sells
-
73
Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q1 2023
As of 31 Mar 2023,
GoodRx Holdings, Inc. - Common Stock (GDRX) was held by
151 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
136,443,326 shares.
The largest 10 holders included
Francisco Partners Management, LP, VANGUARD GROUP INC, Silver Lake Group, L.L.C., MILLENNIUM MANAGEMENT LLC, Petrus Trust Company, LTA, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., ORBIMED ADVISORS LLC, Technology Crossover Management X, Ltd., and MORGAN STANLEY.
This page lists
151
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.